In Thursday’s Wall Street session, Black Diamond Therapeutics Inc (NASDAQ:BDTX) shares traded at $1.67, up 5.03% from the previous session.
BDTX stock price is now -20.88% away from the 50-day moving average and -54.13% away from the 200-day moving average. The market capitalization of the company currently stands at $94.63M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $20, Raymond James recently initiated with Outperform rating for Black Diamond Therapeutics Inc (NASDAQ: BDTX). , while ‘Stifel’ rates the stock as ‘Buy’
In other news, BIOTECH GROWTH N V, 10% Owner sold 5,784,292 shares of the company’s stock on Mar 19 ’25. The stock was sold for $11,997,749 at an average price of $2.07. Upon completion of the transaction, the 10% Owner now directly owns 2,733,547 shares in the company, valued at $4.57 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 28 ’24, 10% Owner Versant Venture Capital VI, L. sold 221,600 shares of the business’s stock. A total of $1,400,556 was realized by selling the stock at an average price of $6.32. This leaves the insider owning 3,726,341 shares of the company worth $6.22 million. A total of 23.86% of the company’s stock is owned by insiders.
During the past 12 months, Black Diamond Therapeutics Inc has had a low of $1.57 and a high of $7.66. As of last week, the company has a debt-to-equity ratio of 0.27, a current ratio of 4.92, and a quick ratio of 4.92. The fifty day moving average price for BDTX is $2.1106 and a two-hundred day moving average price translates $3.64035 for the stock.
The latest earnings results from Black Diamond Therapeutics Inc (NASDAQ: BDTX) was released for 2024-12-31.
